Literature DB >> 10426400

Programmed cell death in the terminal endbud.

R C Humphreys1.   

Abstract

Ductal development in the pubertal mouse mammary gland is characterized by dramatic morphological changes in the epithelium driven by proliferation of cap and body cells in the terminal endbuds. Recent experiments revealed a coincident and abundant apoptosis in the body cells of these structures. The cells undergoing apoptosis are occasionally restricted to defined regions within the terminal endbud. Localization adjacent to the presumptive lumina suggests that this process functions to sculpt the lumina of the subtending duct. Members of the Bcl-2 family of apoptosis regulatory molecules; Bcl-2 and Bcl-x, appear to have some role in regulating apoptosis in the terminal endbud. Other possible signals which could regulate this developmental process and a model are presented.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10426400     DOI: 10.1023/a:1018733426625

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  45 in total

1.  DNA labeling index and structure of the rat mammary gland as determinants of its susceptibility to carcinogenesis.

Authors:  J Russo; I H Russo
Journal:  J Natl Cancer Inst       Date:  1978-12       Impact factor: 13.506

2.  Regulation of mammary morphogenesis: evidence for extracellular matrix-mediated inhibition of ductal budding by transforming growth factor-beta 1.

Authors:  G B Silberstein; K C Flanders; A B Roberts; C W Daniel
Journal:  Dev Biol       Date:  1992-08       Impact factor: 3.582

3.  Inhibition of mouse mammary ductal morphogenesis and down-regulation of the EGF receptor by epidermal growth factor.

Authors:  S Coleman; C W Daniel
Journal:  Dev Biol       Date:  1990-02       Impact factor: 3.582

4.  Epithelial cell types and their evolution in the rat mammary gland determined by immunological markers.

Authors:  R Dulbecco; M Unger; B Armstrong; M Bowman; P Syka
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

5.  Development of the mammary gland.

Authors:  C H Knight; M Peaker
Journal:  J Reprod Fertil       Date:  1982-07

Review 6.  Regulation of mammary growth and function by TGF-beta.

Authors:  C W Daniel; S D Robinson
Journal:  Mol Reprod Dev       Date:  1992-06       Impact factor: 2.609

7.  Susceptibility of the mammary gland to carcinogenesis: I Differentiation of the mammary gland as determinant of tumor incidence and type of lesion.

Authors:  J Russo; G Wilgus; I H Russo
Journal:  Am J Pathol       Date:  1979-09       Impact factor: 4.307

8.  Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development.

Authors:  J P Witty; J H Wright; L M Matrisian
Journal:  Mol Biol Cell       Date:  1995-10       Impact factor: 4.138

9.  Intact and amino-terminally shortened forms of insulin-like growth factor I induce mammary gland differentiation and development.

Authors:  W Ruan; C B Newman; D L Kleinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

10.  Epithelium-dependent extracellular matrix synthesis in transforming growth factor-beta 1-growth-inhibited mouse mammary gland.

Authors:  G B Silberstein; P Strickland; S Coleman; C W Daniel
Journal:  J Cell Biol       Date:  1990-06       Impact factor: 10.539

View more
  12 in total

Review 1.  Establishing a framework for the functional mammary gland: from endocrinology to morphology.

Authors:  Russell C Hovey; Josephine F Trott; Barbara K Vonderhaar
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-01       Impact factor: 2.673

Review 2.  Leukocytes in mammary development and cancer.

Authors:  Lisa M Coussens; Jeffrey W Pollard
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-03-01       Impact factor: 10.005

Review 3.  Role of insulin-like growth factor binding proteins in mammary gland development.

Authors:  D J Flint; E Tonner; J Beattie; G J Allan
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-11-08       Impact factor: 2.673

Review 4.  Bcl-2 gene family and related proteins in mammary gland involution and breast cancer.

Authors:  K Schorr; M Li; S Krajewski; J C Reed; P A Furth
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-04       Impact factor: 2.673

Review 5.  The insulin-like growth factors (IGFs) and IGF binding proteins in postnatal development of murine mammary glands.

Authors:  T L Wood; M M Richert; M A Stull; M A Allar
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-01       Impact factor: 2.673

6.  Mfge8 is critical for mammary gland remodeling during involution.

Authors:  Kamran Atabai; Rafael Fernandez; Xiaozhu Huang; Iris Ueki; Ahnika Kline; Yong Li; Sepid Sadatmansoori; Christine Smith-Steinhart; Weimin Zhu; Robert Pytela; Zena Werb; Dean Sheppard
Journal:  Mol Biol Cell       Date:  2005-09-29       Impact factor: 4.138

Review 7.  Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.

Authors:  David L Kleinberg; Teresa L Wood; Priscilla A Furth; Adrian V Lee
Journal:  Endocr Rev       Date:  2008-12-15       Impact factor: 19.871

8.  IGF-I, GH, and sex steroid effects in normal mammary gland development.

Authors:  David L Kleinberg; Weifeng Ruan
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-11-25       Impact factor: 2.673

9.  Expression of NR5A2, NUP153, HNF4A, USP15 and FNDC3B is consistent with their use as novel biomarkers for bovine mammary stem/progenitor cells.

Authors:  Ratan K Choudhary; Anthony V Capuco
Journal:  J Mol Histol       Date:  2021-01-05       Impact factor: 2.611

10.  Loss of protein kinase C delta alters mammary gland development and apoptosis.

Authors:  B L Allen-Petersen; M R Miller; M C Neville; S M Anderson; K I Nakayama; M E Reyland
Journal:  Cell Death Dis       Date:  2010       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.